Dutasteride is more powerful than finasteride at blocking the hormone that drives hair loss and prostate growth, but “better” depends on what you’re treating and how you weigh the tradeoffs. Dutasteride lowers DHT (the hormone responsible for shrinking hair follicles and enlarging the prostate) by about 90%, compared to finasteride’s 70%. That extra suppression translates to a measurable edge for hair regrowth, though the two drugs perform nearly identically for prostate symptoms. The catch: dutasteride isn’t FDA-approved for hair loss, it stays in your body far longer, and its side effect profile is similar enough that the stronger option isn’t automatically the smarter one.
How the Two Drugs Work Differently
Both drugs work by blocking enzymes that convert testosterone into DHT, the more potent androgen that miniaturizes hair follicles and stimulates prostate tissue growth. The key difference is scope. Finasteride blocks only one of the two enzyme types involved in DHT production (type 2), while dutasteride blocks both (types 1 and 2). That dual inhibition is why dutasteride achieves roughly 93% suppression of DHT in the blood, while finasteride reaches about 70%.
Both drugs also reduce DHT concentrations directly in scalp tissue, not just in the bloodstream. The reductions are dose-dependent for each, but dutasteride consistently produces deeper suppression at its standard 0.5 mg dose than finasteride does at its hair loss dose of 1 mg.
The Hair Loss Comparison
For androgenetic alopecia (pattern hair loss), dutasteride’s stronger DHT suppression does appear to produce better results. Systematic reviews comparing the two drugs show that dutasteride leads to greater hair regrowth and more reversal of follicle miniaturization in both men and women. The difference isn’t dramatic for everyone, but it’s consistent across studies: more new hairs and thicker existing hairs with dutasteride compared to finasteride.
That said, finasteride works well for the majority of people who take it. It’s been the standard medical treatment for pattern hair loss for decades and produces visible improvement in most users. Dutasteride tends to be considered a second-line option, something to try if finasteride alone isn’t producing satisfactory results. Some clinicians start patients on finasteride first because it’s FDA-approved for hair loss, better studied in that context, and leaves the body much faster if problems arise.
For Prostate Enlargement, They’re Close
The picture changes when you look at benign prostatic hyperplasia (BPH). A large head-to-head trial called EPICS compared dutasteride 0.5 mg to finasteride 5 mg in men over 50 with enlarged prostates and found no significant difference between the two after 12 months. Both drugs produced similar improvements in urinary symptoms, urinary flow rate, and prostate volume reduction.
Longer-term data from separate trials does show a slight numerical advantage for dutasteride. Over two to four years, dutasteride reduced prostate volume by roughly 26 to 27%, compared to 16 to 18% for finasteride. Urinary flow improved by 2.2 to 2.7 mL/sec with dutasteride versus 1.7 to 2.2 mL/sec with finasteride. A real-world retrospective study confirmed this pattern, finding a statistically significant difference in prostate volume reduction (26.3% vs. 18.1%) but no significant difference in urinary flow improvement. Both drugs reduced the risk of acute urinary retention by about 57% at their respective study timepoints, and both substantially lowered the likelihood of needing prostate surgery.
In practical terms, most men with BPH would notice similar symptom relief from either drug. The measurable differences in prostate shrinkage may matter more for men with very large prostates or those at higher risk of complications.
A Major Difference in Half-Life
One of the most important practical distinctions between these drugs has nothing to do with effectiveness. Finasteride has a half-life of 6 to 8 hours, meaning it clears your system within a day or two of stopping. Dutasteride’s half-life is approximately 5 weeks. That means it takes several months for dutasteride to fully leave your body after you stop taking it.
This matters for two reasons. First, if you experience side effects on dutasteride, those effects may linger for weeks or months after discontinuation, whereas finasteride-related side effects typically resolve much faster. Second, for anyone planning a pregnancy with a partner, the washout period for dutasteride is significantly longer. Both drugs can affect fetal development and are contraindicated during pregnancy, so the timeline for safely discontinuing matters.
Side Effects Are Similar
Both drugs carry the same general category of side effects, primarily sexual in nature: reduced libido, erectile difficulties, and decreased ejaculate volume. Clinical trials for BPH found a similar percentage of adverse events in both treatment groups, with no new safety signals emerging during extended use. The rates of these sexual side effects are relatively low for both drugs, typically affecting a single-digit percentage of users.
Because dutasteride suppresses DHT more aggressively, there’s a theoretical concern that sexual side effects could be more frequent or pronounced. Some studies have found marginally higher rates with dutasteride, but the differences are small and not always statistically significant. The more relevant concern for most people is the half-life issue: if side effects do occur, they resolve faster with finasteride.
FDA Approval and Availability
Finasteride is FDA-approved for both hair loss (at 1 mg) and BPH (at 5 mg). Dutasteride is FDA-approved only for BPH at 0.5 mg. For hair loss, dutasteride has received approval only in South Korea and Japan. In the United States and most other countries, prescribing dutasteride for hair loss is considered off-label use.
Off-label doesn’t mean unsafe or unsupported by evidence. It simply means the manufacturer hasn’t gone through the specific regulatory process for that indication. Many dermatologists prescribe dutasteride off-label for hair loss, particularly when patients haven’t responded well to finasteride. However, the off-label status can affect insurance coverage and means there’s less standardized dosing guidance compared to finasteride.
Which One Makes Sense for You
If you’re treating hair loss and finasteride is working, there’s little reason to switch. Dutasteride becomes a more compelling option when finasteride hasn’t produced adequate results after 12 months or more, since its stronger DHT suppression can push some non-responders into visible improvement territory. Starting with finasteride is a reasonable approach because it’s approved for hair loss, clears the body quickly, and works for most people.
For BPH, the two drugs are close enough in effectiveness that the choice often comes down to physician preference, cost, and formulary availability. Men with very large prostates may benefit slightly more from dutasteride’s deeper DHT suppression, but for the average BPH patient, either drug will produce meaningful symptom relief. The long half-life of dutasteride is worth keeping in mind if you value the ability to stop and reverse course quickly.